Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Pediatric Blood & Cancer|July 10, 2021
Impact of central nervous system-directed treatment on competence and adjustment among children in early cancer survivorshipAdrien M Winning, Emily L Moscato, Vicky Lehmann, et al.
American Journal of Hematology|December 9, 2017
Clinical experience with the BCL2-inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignanciesCourtney D DiNardo, Caitlin R Rausch, Christopher Benton, et al.
Physical Review Letters|June 18, 2025
Atacamite Cu_{2}Cl(OH)_{3} in High Magnetic Fields: Quantum Criticality and Dimensional Reduction of a Sawtooth-Chain CompoundL Heinze, T Kotte, R Rausch, et al.
Leukemia & Lymphoma|April 8, 2021
Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemiaLydia L Benitez, Anthony J Perissinotti, Caitlin R Rausch, et al.
Headache|March 19, 2016
Cognitive Behavioral Therapy plus Amitriptyline for Children and Adolescents with Chronic Migraine Reduces Headache Days to ≤4 Per MonthJohn W Kroner, Andrew D Hershey, Susmita M Kashikar-Zuck, et al.
Blood Cancer Journal|June 27, 2026
Inotuzumab ozogamicin therapy for measurable residual disease in adult acute lymphoblastic leukemiaElias Jabbour, Caitlin R Rausch, Hannah Goulart, et al.
American Journal of Hematology|March 26, 2025
Multicenter Retrospective Evaluation of Treatment for High-Risk Acute Promyelocytic Leukemia: Real-World Outcomes From the HERO ConsortiumLydia L Benitez, Kayleigh R Marx, Caitlin R Rausch, et al.
Leukemia & Lymphoma|August 12, 2021
Clinical and molecular characterization of myeloid sarcoma without medullary leukemiaHussein A Abbas, Patrick K Reville, Alexis Geppner, et al.
Acta Haematologica|May 12, 2020
Treating Leukemia in the Time of COVID-19Shilpa Paul, Caitlin R Rausch, Nitin Jain, et al.
American Journal of Hematology|April 12, 2022
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trialsKunhwa Kim, Marina Konopleva, Courtney D DiNardo, et al.
Pageof 15